| Name | RPH-2823 |
|---|---|
| Synonyms |
1-(Dimethylamino)-3-[4-(2,4,7-triamino-6-pteridinyl)phenoxy]-2-propanol
2-Propanol, 1-(dimethylamino)-3-[4-(2,4,7-triamino-6-pteridinyl)phenoxy]- |
| Description | RPH-2823 is a basic triamterene derivative, with diuretic activity. |
|---|---|
| Related Catalog | |
| In Vitro | RPH 2823 induces a dose-dependent decrease in SCC and increase in transepithelial electrical resistance. RPH 2823 influences transepithelial Na+ transport by interacting with the Na+ channel or a regulator site of it within the apical membrane[1]. |
| In Vivo | RPH 2823 (2.5 mumol/kg) can avoid the kaliuresis of 25 mumol/kg furosemide in male Wistar rats. RPH 2823 (1 mg/kg and 5 mg/kg, i.v.) has a terminal elimination half-life of 3 h. About 47% of the given dose are excreted unchanged with urine[2]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 690.8±65.0 °C at 760 mmHg |
| Molecular Formula | C17H22N8O2 |
| Molecular Weight | 370.409 |
| Flash Point | 371.6±34.3 °C |
| Exact Mass | 370.186584 |
| LogP | 0.47 |
| Vapour Pressure | 0.0±2.3 mmHg at 25°C |
| Index of Refraction | 1.720 |
| Storage condition | 2-8℃ |